WOLLENBERG, A.; CORK, M.; HONG, C.-H.; KURBASIC, A.; VACKO, E.; PALLER, A. Progressive and Sustained Disease Control in Patients with Atopic Dermatitis (AD) Aged 12–17 Years Treated with Tralokinumab for 52 Weeks. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s377, 2024. DOI: 10.25251/skin.8.supp.377. Disponível em: https://jofskin.org/index.php/skin/article/view/2680. Acesso em: 22 jul. 2024.